home / stock / casi / casi news

CASI News and Press, CASI Pharmaceuticals Inc. From 09/22/19

Stock Information
Company Name: CASI Pharmaceuticals Inc.
Stock Symbol: CASI
Market: NASDAQ
Website: casipharmaceuticals.com
Menu
CASI CASI Quote CASI Short CASI News CASI Articles CASI Message Board
Get CASI Alerts

News, Short Squeeze, Breakout and More Instantly...
CASI - Week In Review: Investor Group Bids $4.6 Billion To Acquire China Biologic

Deals and Financings China Biologic Products (CBPO), a blood products company, received a $4.6 billion takeover offer from a group of six investment firms (see story ). The proposal was priced at $120 per share, a 16% premium to the previous close. CBPO operates plasma-gathering facilities ...
CASI - New president at CASI Pharma

CASI Pharmaceuticals (NASDAQ: CASI ) promotes Larry Zhang to President. More news on: CASI Pharmaceuticals, Inc., Healthcare stocks news, Read more ...

CASI - CASI Pharmaceuticals Announces The Promotion Of Larry Zhang To President

ROCKVILLE, Md. , Sept. 19, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products, announces the promotion of Larry Zhang to President. Wei-Wu He , Ph....

CASI - China NMPA Accepts Clinical Trial Application For CASI's CD19 CAR-T-Product

ROCKVILLE, Md. , Sept. 16, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products, announces that the Chinese National Medical Product Administration (NMPA), the Ch...
CASI - CASI Pharmaceuticals (CASI) Investor Presentation - Slideshow

The following slide deck was published by CASI Pharmaceuticals, Inc. in conjunction with this Read more ...

CASI - CASI Pharmaceuticals, Inc. to Host Key Opinion Leader Symposium on September 10, 2019 in New York City

ROCKVILLE, Md. , Sept. 5, 2019 /PRNewswire/ --   CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China , U.S., and throughout the world, announces it will host a key opi...

CASI - CASI Pharmaceuticals, Inc. To Present At The 2019 H.C. Wainwright 21st Annual Global Investment Conference

ROCKVILLE, Md. , Sept. 3, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China , U.S., and throughout the world, announces it will present at the 2019 H...
CASI - CASI Pharma launches EVOMELA in China

CASI Pharmaceuticals (NASDAQ: CASI )  announces the product launch of EVOMELA (melphalan for injection) in China. More news on: CASI Pharmaceuticals, Inc., Healthcare stocks news, Read more ...

CASI - CASI Pharmaceuticals Announces Launch of EVOMELA® (melphalan for injection) in China

ROCKVILLE, Md. , Aug. 12, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China , U.S., and throughout the world, announces the product launch of EVOMELA...

CASI - CASI Pharmaceuticals EPS misses by $0.07

CASI Pharmaceuticals (NASDAQ: CASI ): Q2 GAAP EPS of -$0.16 misses by $0.07 . More news on: CASI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Previous 10 Next 10